Advertisement

Clinical Research in Cardiology

, Volume 107, Issue 7, pp 586–596 | Cite as

Combined use of lung ultrasound, B-type natriuretic peptide, and echocardiography for outcome prediction in patients with acute HFrEF and HFpEF

  • Alberto Palazzuoli
  • Gaetano Ruocco
  • Matteo Beltrami
  • Ranuccio Nuti
  • John G. Cleland
Original Paper

Abstract

Background

Lung ultrasound (LUS) can be used to assess pulmonary congestion by imaging B-lines (‘comets’) for patients with acute heart failure (AHF).

Objectives

Investigate relationship of B-lines, plasma concentrations of B-type natriuretic peptide (BNP), and echocardiographic left ventricular (LV) function measured at admission and discharge and their relationship to prognosis for AHF with preserved (HFpEF) or reduced (HFrEF) LV ejection fraction.

Methods

Patients with AHF had the above tests done at admission and discharge. The primary outcome was re-hospitalization for heart failure or death at 6 months.

Results

Of 162 patients enrolled, 95 had HFrEF and 67 had HFpEF, median age was 80 [77–85] years, and 85 (52%) were women. The number of B-lines at admission (median 31 [27–36]) correlated with respiratory rate (r = 0.75; p < 0.001), BNP (r = 0.43; p < 0.001), clinical congestion score (r = 0.25; p = 0.001), and systolic pulmonary artery pressure (r = 0.42; p < 0.001). At discharge, B-lines were also correlated with BNP (r = 0.69; p < 0.001) and congestion score (r = 0.57; p < 0.001). B-line count at discharge predicted outcome (AUC 0.83 [0.77–0.90]; univariate HR 1.12 [1.09–1.16]; p < 0.001; multivariable HR 1.16 [1.11–1.21]; p < 0.001). Results were similar for HFpEF and HFrEF.

Conclusions

LUS appears a useful method to assess severity and monitor the resolution of lung congestion. At hospital admission, B-lines are strongly related to respiratory rate, which may be a key component of the sensation of dyspnea. Measurement of lung congestion at discharge provides prognostic information for patients with either HFpEF or HFrEF.

Keywords

LUS Acute HF HFpEF HFrEF Risk stratification 

Abbreviations

AHF

Acute heart failure

AF

Atrial fibrillation

BNP

B-type natriuretic peptide

DT

Deceleration time

EF

Ejection fraction

HF

Heart failure

HFpEF

Heart failure with preserved ejection fraction

HFrEF

Heart failure with reduced ejection fraction

IVRT

Isovolumetric relaxation time

LUS

Lung ultrasound

LV

Left ventricular

NP

Natriuretic peptides

PAPs

Systolic pulmonary artery pressure

ROC

Receiving operating characteristics

Notes

Author contributions

AP and GR helped conceive and design the study and interpreted the results AP supervised the research and wrote the first draft of the manuscript. GR provided statistical analysis and revised the manuscript. MB helped acquire data. RN and JGC contributed to data interpretation and revision of the manuscript. All authors gave final approval of the version to be published.

Compliance with ethical standards

Conflict of interest

Dr. Palazzuoli, Ruocco, Beltrami, and Nuti report no relevant conflicts; Prof. J. G. Cleland has received research grants from Amgen, Novartis, and Stealth Biopharmaceuticals.

Supplementary material

392_2018_1221_MOESM1_ESM.tif (80 kb)
Supplementary material 1 (TIF 79 KB)
392_2018_1221_MOESM2_ESM.tif (36 kb)
Supplementary material 2 (TIF 36 KB)

References

  1. 1.
    Gheorghiade M, Zannad F, Sopko G, International Working Group on Acute Heart Failure Syndromes et al (2005) Acute heart failure syndromes: current state and framework for future research. Circulation 112:3958–3968CrossRefPubMedGoogle Scholar
  2. 2.
    Gheorghiade M, Gattis WA, O’Connor CM; Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Congestive Heart Failure (ACTIV in CHF) Investigators et al (2004) Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial. JAMA 291:1963–1971Google Scholar
  3. 3.
    Drazner MH, Rame JE, Stevenson LW, Dries DL (2001) Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med 345:574–581CrossRefPubMedGoogle Scholar
  4. 4.
    Lucas C, Johnson W, Hamilton MA et al (2000) Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure. Am Heart J 140:840–847CrossRefPubMedGoogle Scholar
  5. 5.
    Lala A, McNulty SE, Mentz RJ et al (2015) Relief and recurrence of congestion during and after hospitalization for acute heart failure: insights from diuretic optimization strategy evaluation in acute decompensated heart failure (DOSE-AHF) and cardiorenal rescue study in acute decompensated heart failure (CARESS-HF). Circ Heart Fail 8:741–748CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Damy T, Kallvikbacka-Bennett A, Zhang J et al (2011) Does the physical examination still have a role in patient with suspected heart failure? Eur J Heart Fail 13:1340–1348CrossRefPubMedGoogle Scholar
  7. 7.
    Rohde LE, Beck-da-Silva L, Goldraich L et al (2004) Reliability and prognostic value of traditional signs and symptoms in outpatients with congestive heart failure. Can J Cardiol 20:697–702PubMedGoogle Scholar
  8. 8.
    Chakko S, Woska D, Martinez H et al (1991) Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care. Am J Med 90:353–359CrossRefPubMedGoogle Scholar
  9. 9.
    Ponikowski P, Voors AA, Anker SD; Authors/Task Force Members; Document Reviewers et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18:891–975CrossRefPubMedGoogle Scholar
  10. 10.
    Palazzuoli A, Beltrami M, Ruocco G, Franci B, Campagna MS, Nuti R (2016) Diagnostic utility of contemporary echo and BNP assessment in patients with acute heart failure during early hospitalization. Eur J Intern Med 30:43–48CrossRefPubMedGoogle Scholar
  11. 11.
    Ricci F, Aquilani R, Radico F et al (2015) Role and importance of ultrasound lung comets in acute cardiac care. Eur Heart J Acute Cardiovasc Care 4:103–112CrossRefPubMedGoogle Scholar
  12. 12.
    Gargani L, Frassi F, Soldati G, Tesorio P, Gheorghiade M, Picano E (2008) Ultrasound lung comets for the differential diagnosis of acute cardiogenic dyspnoea: a comparison with natriuretic peptides. Eur J Heart Fail 10:70–77CrossRefPubMedGoogle Scholar
  13. 13.
    Gheorghiade M, Follath F, Ponikowski P; European Society of Cardiology; European Society of Intensive Care Medicine et al (2010) Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail 12:423–433CrossRefPubMedGoogle Scholar
  14. 14.
    Lang RM, Badano LP, Mor-Avi V et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 16:233–270CrossRefPubMedGoogle Scholar
  15. 15.
    Nagueh SF, Smiseth OA, Appleton CP et al (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 17:1321–1360CrossRefPubMedGoogle Scholar
  16. 16.
    Lancellotti P, Galderisi M, Edvardsen T et al (2017) Echo-Doppler estimation of left ventricular filling pressure: results of the multicentre EACVI Euro-Filling study. Eur Heart J Cardiovasc Imaging 18:961–968CrossRefPubMedGoogle Scholar
  17. 17.
    Andersen OS, Smiseth OA, Dokainish H et al (2017) Estimating left ventricular filling pressure by echocardiography. J Am Coll Cardiol 69:1937–1948CrossRefPubMedGoogle Scholar
  18. 18.
    Volpicelli G, Elbarbary M, Blaivas M; International Liaison Committee on Lung Ultrasound (ILC-LUS) for International Consensus Conference on Lung Ultrasound (ICC-LUS) et al (2012) International evidence-based recommendations for point-of-care lung ultrasound. Intensive Care Med 38:577–591CrossRefPubMedGoogle Scholar
  19. 19.
    Jambrik Z, Monti S, Coppola V et al (2004) Usefulness of ultrasound lung comets as a nonradiologic sign of extravascular lung water. Am J Cardiol 93:1265–1270CrossRefPubMedGoogle Scholar
  20. 20.
    Gargani L, Pang PS, Frassi F et al (2015) Persistent pulmonary congestion before discharge predicts rehospitalization in heart failure: a lung ultrasound study. Cardiovasc Ultrasound 13:40CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Coiro S, Rossignol P, Ambrosio G et al (2015) Prognostic value of residual pulmonary congestion at discharge assessed by lung ultrasound imaging in heart failure. Eur J Heart Fail 17:1172–1181CrossRefPubMedGoogle Scholar
  22. 22.
    Platz E, Lewis EF, Uno H et al (2016) Detection and prognostic value of pulmonary congestion by lung ultrasound in ambulatory heart failure patients. Eur Heart J 37:1244–1251CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Miglioranza MH, Gargani L, Sant’Anna RT et al (2013) Lung ultrasound for the evaluation of pulmonary congestion in outpatients: a comparison with clinical assessment, natriuretic peptides, and echocardiography. JACC Cardiovasc Imaging 6:1141–1151CrossRefPubMedGoogle Scholar
  24. 24.
    Cogliati C, Casazza G, Ceriani E et al (2016) Lung ultrasound and short-term prognosis in heart failure patients. Int J Cardiol 218:104–108CrossRefPubMedGoogle Scholar
  25. 25.
    Spevack R, Al Shukairi M, Jayaraman D, Dankoff J, Rudski L, Lipes J (2017) Serial lung and IVC ultrasound in the assessment of congestive heart failure. Crit Ultrasound J 9:7CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Gaggin HK, Truong QA, Rehman SU et al (2013) Characterization and prediction of natriuretic peptide “nonresponse” during heart failure management: results from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) and the NT-proBNP-Assisted Treatment to Lessen Serial Cardiac Readmissions and Death (BATTLESCARRED) study. Congest Heart Fail 19:135–142CrossRefPubMedGoogle Scholar
  27. 27.
    Kubánek M, Goode KM, Lánská V, Clark AL, Cleland JG (2009) The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction. Eur J Heart Fail 11:367–377CrossRefPubMedGoogle Scholar
  28. 28.
    Cleland JG, Teerlink JR, Davison BA; VERITAS Investigators et al (2017) Measurement of troponin and natriuretic peptides shortly after admission in patients with heart failure-does it add useful prognostic information? An analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Studies (VERITAS). Eur J Heart Fail 19:739–747CrossRefPubMedGoogle Scholar
  29. 29.
    Anderson KL, Jenq KY, Fields JM, Panebianco NL, Dean AJ (2013) Diagnosing heart failure among acutely dyspneic patients with cardiac, inferior vena cava, and lung ultrasonography. Am J Emerg Med 31:1208–1214CrossRefPubMedGoogle Scholar
  30. 30.
    Mebazaa A, Yilmaz MB, Levy P et al (2015) Recommendations on pre-hospital and early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine. Eur J Heart Fail 17:544–558CrossRefPubMedGoogle Scholar
  31. 31.
    Pivetta E, Goffi A, Lupia E et al (2015) SIMEU Group for lung ultrasound in the emergency department in piedmont. Lung ultrasound-implemented diagnosis of acute decompensated heart failure in the ED. ASIMEU Multicenter Study. Chest 148:202–210CrossRefPubMedGoogle Scholar
  32. 32.
    Farmakis D, Simitsis P, Bistola V et al (2017) Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome. Clin Res Cardiol 106:359–368CrossRefPubMedGoogle Scholar
  33. 33.
    Cotter G, Moshkovitz Y, Kaluski E et al (2003) The role of cardiac power and systemic vascular resistance in the pathophysiology and diagnosis of patients with acute congestive heart failure. Eur J Heart Fail 5:443–551CrossRefPubMedGoogle Scholar
  34. 34.
    Nohria A, Tsang SW, Fang JC et al (2003) Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol 41:1797–1804CrossRefPubMedGoogle Scholar
  35. 35.
    Hasselblad V, Stough WG, Shah MR et al (2007) Relation between dose of loop diuretics and outcomes in heart failure population: results of the ESCAPE trial. Eur J Heart Fail 9:1064–1069CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Cook TD, Greene SJ, Kalogeropoulos AP et al (2016) Temporal changes in postdischarge mortality risk after hospitalization for heart failure (from the EVEREST Trial). Am J Cardiol 117:611–616CrossRefPubMedGoogle Scholar
  37. 37.
    Filippatos G, Farmakis D, Metra M et al (2017) Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial. Clin Res Cardiol 106:444–456CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Shoaib A, Waleed M, Khan S et al (2014) Breathlessness at rest is not the dominant presentation of patients admitted with heart failure. Eur J Heart Fail 16:1283–1291CrossRefPubMedGoogle Scholar
  39. 39.
    Packer M, O’Connor C, McMurray JJV; TRUE-AHF Investigators et al (2017) Effect of ularitide on cardiovascular mortality in acute heart failure. N Engl J Med;376:1956–1964CrossRefPubMedGoogle Scholar
  40. 40.
    Gimpelewicz C, Metra M, Cleland JGF, Szecsödy P, Chang Wun CC, Boer-Martins L, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Pang P, Ponikowski P, Severin T, Voors AA, Teerlink JR (2017) Effects of serelaxin on the outcome of patients with or without substantial peripheral edema: a subgroup analysis from the RELAX-AHF trial. Am Heart J. 190:13–122.  https://doi.org/10.1016/j.ahj.2017.05.012 CrossRefPubMedGoogle Scholar
  41. 41.
    Greene SJ, Fonarow GC, Vaduganathan M, Khan SS, Butler J, Gheorghiade M (2015) The vulnerable phase after hospitalization for heart failure. Nat Rev Cardiol 12:220–229CrossRefPubMedGoogle Scholar
  42. 42.
    Mentz RJ, Kjeldsen K, Rossi GP et al (2014) Decongestion in acute heart failure. Eur J Heart Fail 16:471–482CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Collins SP, Lindsell CJ, Storrow AB, Abraham WT; ADHERE Scientific Advisory Committee, Investigators and Study Group (2006) Prevalence of negative chest radiography results in the emergency department patient with decompensated heart failure. Ann Emerg Med 47:13–18CrossRefPubMedGoogle Scholar
  44. 44.
    Hummel SL, Ghalib HH, Ratz D, Koelling TM (2013) Risk stratification for death and all-cause hospitalization in heart failure clinic outpatients. Am Heart J 166:895–903.e1CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    O’Connor CM, Abraham WT, Albert NM et al (2008) Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am Heart J 156:662–673CrossRefPubMedGoogle Scholar
  46. 46.
    Cleland JG, Chiswell K, Teerlink JR et al (2014) Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function (PROTECT) Study. Circ Heart Fail 7:76–87CrossRefPubMedGoogle Scholar
  47. 47.
    Cleland JG, Carubelli V, Castiello T, Yassin A, Pellicori P, Antony R (2012) Renal dysfunction in acute and chronic heart failure: prevalence, incidence and prognosis. Heart Fail Rev 17:133–149CrossRefPubMedGoogle Scholar
  48. 48.
    Schroten NF, Damman K, Valente MA et al (2016) Long-term changes in renal function and perfusion in heart failure patients with reduced ejection fraction. Clin Res Cardiol 105:10–16CrossRefPubMedGoogle Scholar
  49. 49.
    Jobs A, Brünjes K, Katalinic A et al (2017) Inferior vena cava diameter in acute decompensated heart failure as predictor of all-cause mortality. Heart Vessels 32:856–864CrossRefPubMedGoogle Scholar
  50. 50.
    Pang PS (2017) B-lines Lung Ultrasound Guided ED Management of Acute Heart Failure Pilot Trial (BLUSHED-AHF). http://www.clinicaltrial.gov (NCT03136198)

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Alberto Palazzuoli
    • 1
  • Gaetano Ruocco
    • 1
  • Matteo Beltrami
    • 1
  • Ranuccio Nuti
    • 1
  • John G. Cleland
    • 2
    • 3
  1. 1.Cardiovascular Diseases Unit, Department of Internal Medicine, S. Maria alle Scotte Hospital SienaUniversity of SienaSienaItaly
  2. 2.National Heart and Lung Institute and National Institute of Health Research Cardiovascular Biomedical Research UnitRoyal Brompton and Harefield Hospitals, Imperial CollegeLondonUK
  3. 3.Robertson Centre for Biostatistics and Clinical TrialsUniversity of GlasgowGlasgowUK

Personalised recommendations